Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2025
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
Stephanie J Lee, Brent Logan, Mary M Horowitz, et al.
The Lancet. Diabetes & Endocrinology
|
September 9, 2024
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials
Claire Vale, Peter J Godolphin, David Fisher, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2024
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial
Jason G Dehn, Brent Logan, Bronwen E Shaw, et al.
Blood Advances
|
June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment Trial
Asad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Transplantation and Cellular Therapy
|
November 10, 2025
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial
Jason G Dehn, Brent Logan, Stephanie J Lee, et al.
Transplantation and Cellular Therapy
|
January 17, 2026
Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trial
Joseph Pidala, Brent Logan, Stephanie J Lee, et al.
Chest
|
November 18, 2023
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life
Yonatan Y Greenstein, Kinsley Hubel, Joshua Froess, et al.
Blood Advances
|
April 30, 2025
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703
Sameem M Abedin, Michael J Martens, Javier Bolaños-Meade, et al.
The New England Journal of Medicine
|
June 21, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703
Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2025
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
Stephanie J Lee, Brent Logan, Mary M Horowitz, et al.
The Lancet. Diabetes & Endocrinology
|
September 9, 2024
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials
Claire Vale, Peter J Godolphin, David Fisher, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2024
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial
Jason G Dehn, Brent Logan, Bronwen E Shaw, et al.
Blood Advances
|
June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment Trial
Asad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Transplantation and Cellular Therapy
|
November 10, 2025
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial
Jason G Dehn, Brent Logan, Stephanie J Lee, et al.
Transplantation and Cellular Therapy
|
January 17, 2026
Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trial
Joseph Pidala, Brent Logan, Stephanie J Lee, et al.
Chest
|
November 18, 2023
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life
Yonatan Y Greenstein, Kinsley Hubel, Joshua Froess, et al.
Blood Advances
|
April 30, 2025
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703
Sameem M Abedin, Michael J Martens, Javier Bolaños-Meade, et al.
The New England Journal of Medicine
|
June 21, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703
Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, et al.
Page
of 5